Rankings
▼
Calendar
MRVI Q3 2020 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
MRVI
Maravai LifeSciences Holdings, Inc.
$970M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$88M
Gross Profit
$68M
77.5% margin
Operating Income
$46M
52.0% margin
Net Income
$39M
44.3% margin
EPS (Diluted)
$0.44
QoQ Revenue Growth
+87.3%
Cash Flow
Operating Cash Flow
$51M
Free Cash Flow
$41M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$650M
Total Liabilities
$702M
Stockholders' Equity
-$53M
Cash & Equivalents
$36M
← FY 2020
All Quarters
Q4 2020 →
